FM-TP3000

FM-TP3000 is a long-acting injectable nanoparticle suspension of triamcinolone pentanoate, a synthetic corticosteroid, being developed by Formosa Pharmaceuticals for the treatment of ocular inflammatory conditions, primarily non-infectious uveitis. The drug utilizes Formosa's proprietary Activ-Polymer Nanoparticle Technology (APNT) to achieve a uniform and stable nanoparticle formulation, which allows for sustained release of the active ingredient within the eye. As a glucocorticoid receptor agonist, triamcinolone pentanoate exerts potent anti-inflammatory and immunosuppressive effects by inhibiting the production of various inflammatory cytokines and enzymes. This localized, long-acting delivery system is designed to improve patient compliance and therapeutic outcomes by reducing the frequency of intravitreal injections and minimizing systemic side effects associated with oral steroids.

Other names

triamcinolone pentanoate nanoparticle